Error in a study of the outcome of mantle cell lymphoma: Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but - Christian H. Geisler, Arne Kolstad, Anna Laurell, Mats Jerkeman, Riikka Räty, Niels S. Andersen, Lone B. Pedersen, Mikael Eriksson, Marie Nordström, Eva Kimby, Hans Bentzen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson-Ehle, Elisabeth Ralfkiaer - Dissemin

Language
Login

Published in

Wiley, British Journal of Haematology, 6(158), p. 815-816, 2012

DOI: 10.1111/bjh.12006

Links

Wiley

Tools

Export citation

Search in Google Scholar

Error in a study of the outcome of mantle cell lymphoma: Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but

Journal article published in 2012 by Christian H. Geisler, Arne Kolstad, Anna Laurell, Mats Jerkeman, Riikka Räty, Niels S. Andersen, Lone B. Pedersen, Mikael Eriksson, Marie Nordström, Eva Kimby, Hans Bentzen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson-Ehle, Elisabeth Ralfkiaer and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO